Cargando…
Implications of the licensure of a partially efficacious malaria vaccine on evaluating second-generation vaccines
BACKGROUND: Malaria is a leading cause of morbidity and mortality, with approximately 225 million clinical episodes and >1.2 million deaths annually attributed to malaria. Development of a highly efficacious malaria vaccine will offer unparalleled possibilities for disease prevention and remains...
Autores principales: | Fowkes, Freya JI, Simpson, Julie A, Beeson, James G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225678/ https://www.ncbi.nlm.nih.gov/pubmed/24228861 http://dx.doi.org/10.1186/1741-7015-11-232 |
Ejemplares similares
-
Malaria vaccine efficacy: the difficulty of detecting and diagnosing malaria
por: O'Meara, Wendy Prudhomme, et al.
Publicado: (2007) -
Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates
por: Chan, Jo-Anne, et al.
Publicado: (2014) -
Vaccine Licensure in the Absence of Human Efficacy Data
por: Finch, Courtney L., et al.
Publicado: (2022) -
Identifying and combating the impacts of COVID-19 on malaria
por: Rogerson, Stephen J., et al.
Publicado: (2020) -
Complement Factors in COVID-19 Therapeutics and Vaccines
por: Kurtovic, Liriye, et al.
Publicado: (2021)